Recent studies underscore that chronic hypoxia in the tubulointerstitium is a final common pathway to progression to end-stage renal failure regardless of etiology. We used microarray analysis of rat kidneys made hypoxic by unilateral renal artery stenosis to measure transcriptomic events and clarify pathophysiological mechanisms of renal injury induced by chronic hypoxia. Many genes were upregulated in the kidney by chronic hypoxia, but we focused on metallothionein due to its antioxidative properties. Using tubular epithelial cells transfected with a reporter construct of luciferase, driven by the hypoxia-responsive elements (HRE), we found that addition of metallothionein to the culture media increased luciferase activity. This was associated with upregulation of the target genes of hypoxia-inducible factor (HIF), such as vascular endothelial growth factor and glucose transporter-1. Stimulation of the HIF-HRE pathway by metallothionein was confirmed by metallothionein overexpression. Hypoxia and exogenous metallothionein increased HIF-1a protein without changes in its mRNA levels, suggesting protein stabilization. Upregulation of the HIF-HRE system by metallothionein was associated with phosphorylation of ERK but not Akt. MEK inhibition and rapamycin decreased metallothionein-induced HIF activity. Our study shows that upregulation of metallothionein expression by hypoxia activates the HIF-HRE system through the ERK/mTOR pathway and may be a novel defense against hypoxia. Chronic hypoxia of the kidney has been implicated in the pathogenesis and progression of chronic kidney disease regardless of the underlying disease.
Chronic hypoxia of the kidney has been implicated in the pathogenesis and progression of chronic kidney disease regardless of the underlying disease. [1] [2] [3] Cellular responses to oxygen are important in many aspects of physiological homeostasis and have been a hot topic in a wide range of fields. However, the underlying pathophysiology of the kidney in chronic hypoxia has not been fully understood.
Many previous studies demonstrated chronic hypoxia in the kidney of a variety of models, including the remnant kidney, 4, 5 chronic progressive glomerulonephritis, 6, 7 puromycin nephrosis, 8 diabetic nephropathy, 9 cisplatin nephropathy, 10 and aging kidney. 11 However, kidneys of these models are confounded by nonhypoxic factors such as proteinuria and hyperglycemia. Recent studies utilizing blood oxygenation level-dependent magnetic resonance imaging (BOLD MRI) suggested that stenotic kidney reveals continuous and progressive hypoxia. 12 Although reduction of renal blood flow can also activate fibrogenic or vasoactive pathways, which modulate cytokines and inflammatory mediators, we employed renal artery stenosis, most common form of ischemic nephropathy, as a model of hypoxic nephropathy in the current study. To clarify a molecular pathogenesis of renal injury induced by chronic hypoxia we decided to perform microarray analysis employing a model of chronic renal artery stenosis. We selected the time points of relatively early stages, days 3 and 7, because we wanted to exclude a potential contribution of nonspecific effects of secondary changes induced by tubulointerstitial damage due to not only hypoxia but other factors such as inflammation and apoptosis as much as possible.
Among the genes upregulated in the stenotic kidney, we focused on metallothionein (MT), which is involved in metal detoxification and also functions as an antioxidant, and examined biological functions of MT in hypoxia.
In in vitro studies, we found that MT activates the hypoxia-inducible factor (HIF)/hypoxia-responsive element (HRE) pathway. This activation of the HIF-HRE system by MT was associated with phosphorylation of extracellular signal-regulated kinase (ERK).
RESULTS

Microarray analysis revealed modified expression of various genes
Of 15,924 genes displayed on the microarray, we observed expression of 5124 genes under the basal conditions of normal rats. A total of 88 genes were induced over twofold change in the stenotic kidney at 3 days, and 120 genes were upregulated over twofold change at 7 days after induction of renal artery stenosis (Table 1) . On the other hand, 26 and 48 genes were suppressed under 0.5-fold change at days 3 and 7, respectively. Expression patterns of 96 genes were consistently altered following renal artery stenosis, including 77 genes that were upregulated over twofold and 19 genes downregulated under 0.5-fold at both periods examined. The identified genes are tabulated in Tables 1 and 2 . Among the genes that displayed consistent changes in expression on the microarrays at days 3 and 7, 30 were expressed sequence tags. The effect of chronic hypoxia was observed in various classes of genes, including inflammatory mediators, growth factors, and adhesion molecules. Among them were genes previously implicated in the pathogenesis of ischemic injury (for example, intercellular adhesion molecule-1 and kidney injury molecule (KIM)-1). Figure 1 ). These findings showed that hypoxia upregulates the expression of MT mRNA both in vivo and in vitro.
MT was predominantly increased in the proximal tubules of chronic hypoxic kidneys
We performed immunohistochemical staining of MT. Staining of MT in tubules of the normal kidney was very faint, and glomeruli were negative (Figure 2a ). We observed upregulation of MT in the proximal tubules at 3 days after induction of hypoxia (Figure 2b ). The increased staining persisted at 7 days after the induction (Figure 2c) . We also performed an antibody absorption test using the monoclonal antibody preincubated with MT, and observed no positive staining (Figure 2d ). These results were also confirmed by western blot analysis, which demonstrated that chronic ischemia increased MT protein levels (fivefold at 3 days and threefold at 7 days) compared with normal kidneys (Figure 2e ).
A proinflammatory factor or oxidative stress was not responsible for MT upregulation
As upregulation of MT in the stenotic kidney might be affected by other confounding factors such as inflammation and oxidative stress, we investigated in vitro changes in MT expression by addition of tumor-necrosis factor-a (TNF-a) as a proinflammatory cytokine or hydrogen peroxide as a source of oxidative stress. Although addition of zinc as a positive control markedly increased MT expression, TNF-a and hydrogen peroxide failed to induce any changes in MT expression ( Figure 3 ).
MT enhanced activation of the HIF-HRE pathway in both normoxic and hypoxic conditions
To evaluate effects of MT on HIF activation, we measured luciferase (LUC) activity controlled by HRE in HRE-LUCimmortalized rat proximal tubular cell (IRPTC). Enhancement of HIF activation by MT was observed in a dose-dependent manner under the hypoxic condition (control: 374,909 ± 14,254, MT 250 nM: 630,266 ± 8215, MT 1250 nM: 1,119,243 ± 34,000, n ¼ 3 each) ( Figure 4a ). LUC activity was also increased by MT stimulation under the normoxic condition (control: 237,019 ± 12,167, MT 250 nM: 286,820 ± 10,063, MT 1250 nM: 314,803±9593, n ¼ 3 each). Next, in order to confirm the HIF-HRE pathway activation, we examined the target genes of HIF-HRE systems, vascular endothelial growth factor, Glut-1, and HO-1. MT stimulation increased mRNA levels of these genes both under normoxic and hypoxic conditions. Fold increases of each mRNA expression compared with control were 2.23 ± 0.09-, 3.17 ± 0.24-, and 3.47 ± 0.22-fold, respectively, under normoxia (n ¼ 6 each). Under hypoxia, those compared with those of hypoxic baseline were also 1.82±0.11-, 1.87±0.08-, and 1.34 ± 0.06-fold, respectively (n ¼ 6 each) (Figure 4b ).
To verify the results above, we performed quantitative RT-PCR and western blot analysis of HIF-1a. Neither hypoxia nor MT stimulation increased mRNA levels of HIF-1a, but both of them increased the protein level of HIF-1a, which demonstrated that not only hypoxic stimulation but also MT stimulation stabilized the HIF-1a protein (Figure 5a and b) .
Overexpression of MTs also activated the HIF-HRE pathway
To rule out an artifact of contamination in the MT reagent, we further analyzed HEK293T transiently transfected with a vector plasmid of MTs. At 36 h after the transfection, LUC activities of human MT-1 and human MT-2-transfected HRE-LUC HEK293T rose to 402,805 ± 23,794, and 322,261±23,201, respectively, as compared to that of empty vector transfected cells, 237,017±15,470 (Figure 6a ). These findings showed that overexpressed MT activates the HIF-HRE pathway and may protect cells from hypoxic injury.
Iron chelation was not responsible for HIF induction by MT
Degradation of HIF requires prolyl hydroxylase which needs iron as a cofactor. To investigate whether MT, a metal chelating agent, might stabilize HIF by iron chelation, we added abundant iron to the medium. We did not observe any changes of MT-induced HRE-LUC activity in the presence of excessive iron. These findings showed that iron chelation was not responsible for HIF induction by MT under our experimental conditions (Figure 6b ).
MT activates the HIF-HRE system through the MEK/ERK pathway
To elucidate a mechanism of activation of the HIF-HRE systems by MT, we examined involvement of mammalian target of rapamycin (mTOR). Rapamycin, mTOR inhibitor, significantly reduced the LUC activity increased by MT stimulation (Figure 7a ). These concentrations of rapamycin did not have any influence on cell viability by the lactate dehydrogenase assay (data not shown). MT did not phosphorylate Akt (Figure 7b) , which suggested that the PI3K/Akt pathway, at the upstream of mTOR, was not involved in the activation of the HRE-HIF pathway by MT. Next, we investigated a function of the mitogen-activated protein kinase/ERK kinase (MEK)/ERK pathway. U0126, MEK inhibitor, significantly reduced the LUC activity increased by MT stimulation (Figure 7c ) in both normoxic and hypoxic conditions. Furthermore, as shown in Figure 7d , MT phosphorylated ERK without affecting total ERK. Our findings of phosphorylation of ERK by MT and blunting of the HIF-HRE pathway by inhibition of the MEK/ERK pathway suggest that this pathway mediates activation of the HIF-HRE system by MT.
DISCUSSION
In this study, we utilized cDNA microarray technology to define global changes in renal gene expression during chronic hypoxia of the kidney. Microarray-based analysis identified a broad range of genes whose mRNA levels are altered in response to chronic hypoxia of the kidney, including known genes previously implicated in the pathogenesis of acute ischemia/reperfusion injury (for example, KIM-1). Microarray technology has been applied to an acute ischemia model of the kidney [13] [14] [15] [16] [17] as well as to acute ischemia of culture tubular cells, 18 but according to our knowledge, this is the first study with this technology focusing on chronic hypoxia of the kidney.
To clarify a molecular pathomechanism of chronic hypoxia, we employed a model of chronic renal artery stenosis, because this model is not confounded by factors such as proteinuria and hyperglycemia. Although this model is known as 2K1C and has been used in studies on hypertension, it has also been used to study chronic renal ischemia. Histological changes observed in this study were consistent with previous reports, 19 and we confirmed chronic hypoxia at these time points using hypoxia-sensing rat carrying the HRE-driven tagged luciferase gene in our previous report. 20 Although we excluded obviously necrotic samples from our analysis, we cannot ignore possible contributions of inflammatory changes or apoptosis to MT expression in the stenotic kidney.
The deletorious responses of renal cells to a hypoxic insult include transdifferentiation, 21 cell death, [22] [23] [24] production of extracellular matrix, 25, 26 and so on. Our studies demonstrated that chronic hypoxia induced changes of expression of a variety of classes of genes, including growth factors, kinases, poteases and protease inhibitors, adhesion molecules, and other genes. Our quantitative real-time PCR analysis validated the results of microarray studies. Among these, we focused on MT.
MT is a low molecular weight, cystein-rich, and highly inducible protein. MT binds heavy metal (zinc, copper, selenium, and so on) with high affinity through the thiol group of its cysteine residues, and it is involved in metal detoxification. MT also functions as a scavenger of free radicals due to its many cystein residues. MT gene expression is induced by a variety of stimuli, such as metal exposure, oxidative stress, glucocorticoids, and also hypoxia. 27 In mammals, four major subfamilies exist (MT-1, -2, -3, -4) , of which MT-1 and MT-2 are the most widely expressed isoforms in the body. In humans, the known functional MT-1 and MT-2 isoforms are MT-1A, B, E, F, G, H, X, and MT-2A. However, to date, a specific function, regulation, and expression of each isoform remains to be elucidated. 28 We observed upregulation of MT in proximal tubules of the chronically hypoxic kidney. Previous studies identified MT in the cytoplasm and nuclei of a proximal tubules, which were upregulated by copper injection 29 or, in addition, in distal tubules and parietal wall of Bowman's capsule by exposure to gasoline. 30 We, for the first time, demonstrated upregulation of MT in the kidney by hypoxia, although upregulation of MT by a decrease in oxygen tensions has been observed in cancer cells. 31 The degree of upregulation of MT by hypoxia in vivo was much more than that in cultured tubular cells. This may be due to enhanced MT expression by other factors such as oxidative stress 32 in addition to a decrease in oxygen tensions.
MT protects cells as an antioxidant. Previous studies reported that MT protects islets, 33 hearts, 34, 35 cardiomyocytes 36 from hypoxia, and the protective mechanism includes antiapoptotic effects by scavenging most reactive oxygen species. 35 In this study, we demonstrated that MT protects the kidney against hypoxia through another novel mechanism, stabilization of HIF. We confirmed upregulation of HIF by two independent studies, stimulation of cultured cells by addition of MT in the culture media and by transient transfection of MT-expressing vectors. A previous report showed that MT at the concentrations we employed in this study does not have any influences on cell viability, 37 and we confirmed lack of toxicity of MT by the lactate dehydrogenase assay. HIF is a master switch of defensive mechanisms against hypoxia and is known to be regulated mainly at the degradation step of the protein. 38, 39 Our observations are further supported by a recent finding by Feng et al., 40 who reported that MT-overexpression increased HIF-1a protein level in cardiomyocytes under diabetic conditions. Although it is still a matter of debate, some studies demonstrated that oxidative stress suppresses the HIF-HRE pathway. [41] [42] [43] [44] Scavenging of ROS by MT 33 may, at least in part, has a function in upregulation of HIF under hypoxic conditions which are known to be associated oxidative stress, although this mechanism is unlikely in normoxia. MT is a metalbinding protein with zinc as a major substrate. Thus, theoretically MT may inactivate factor inhibiting HIF by providing zinc with a subsequent increase in HIF expression at the mRNA level. 45 However, this was not the mechanism of HIF activation by MT as we did not observe any changes of HIF mRNA levels. Our studies showed that upregulation of HIF-1a by MT was likely due to stabilization of the protein.
We speculated that extracellular MT may stabilize HIF at the protein level and investigated which signal transduction pathway was responsible. MT may activate an intracellular signaling pathway by binding to its receptor. 46 Otherwise, MT may be taken up into tubular cells by endocytosis with a subsequent stimulation of an intracellular signaling cascade. 47, 48 A number of studies suggested that the PI3K/Akt/ mTOR pathway and/or the MEK/ERK pathway are involved in activation of the HIF/HRE system in addition to hypoxic stimuli. [49] [50] [51] These observations were further confirmed by transfection of a constitutively active or dominant-negative form of Akt, 52 and also of a constitutive active form of MEK-2 49 into cancer cells. As we observed that rapamycin significantly reduced the LUC activity induced by MT stimulation, we first focused attention on the receptor tyrosine kinase (RTK)/PI3K/Akt pathway, upstream of mTOR. However, MT stimulation did not phosphorylate Akt, which suggested that MT regulated steps leading to mTOR independently of RTK/PI3K. Although these results do not exclude a possible contribution of receptor tyrosine kinases to activation of the HIF/HRE pathway which is likely to occur through multiple mechanisms in the stenotic kidney in vivo, we next investigated a contribution of ERK to activation of the HIF/HRE pathway by MT.
MT phosphorylates ERK possibly by release of zinc by stimuli such as oxidative stress, 53 and the function of phosphorylation by the MEK/ERK pathway in the stabilization of HIF-1a transactivity by facilatating the interaction between p300 and HIF-1a has also been demonstrated under normoxic conditions 49, 51, 54 as well as under the hypoxic conditions. 55 Therefore, we studied a function of the MEK/ ERK pathway in stimulation of the HIF-HRE pathway by MT. Our data demonstrated that inhibition of MEK/ERK activation by U0126 blunted the activation of the HIF-HRE pathway by MT. Thus, MT stimulated the MEK/ERK pathway, leading to stimulation of mTOR and subsequent stabilization of HIF at the protein level in our studies. Induction of HIF by MT seems to be more prominent under hypoxia than under normoxia. Li et al. 55 reported that phosphorylated ERK was temporally upregulated ahead of HIF-1a protein in developing rat brain after bilateral carotid artery ligation. We suppose that hypoxia exhibits the synergic effect on phosphorylating ERK by MT, followed by activation of HIF.
In conclusion, using DNA microarray we have identified 131 genes that increase in mRNA expression and 55 genes that decrease in the course of chronic hypoxia. Among these, we focused on antioxidants, MT. We confirmed upregulation of MT by real-time quantitative PCR as well as immunohistochemical analysis. Furthermore, we demonstrated that MT activates the HIF-HRE pathway by stimulation of the MEK/ERK/mTOR pathway. Induction of MT by hypoxia may protect organs against by the novel mechansim, that is stabilization of HIF.
MATERIALS AND METHODS
Experimental animals and induction of chronic hypoxia in the kidney Male Sprague-Dawley rats (Nippon Seibutsu Zairyo Center Co., Saitama, Japan) at the age of 8 weeks were used in this study. All rats were housed in a specific pathogen-free facility and were confirmed to be negative for common viral pathogens by routine sera analyses. All experiments were conducted in accordance with the Guide for Animal Experimentation at the University of Tokyo. Chronic hypoxia of the kidney was induced as previously described. 20 Briefly, a U-shaped silver clip (0.23 mm internal diameter) was placed around the left renal artery, and at 3 days or 7 days after the procedure kidneys were harvested for analysis described below.
High-density oligonucleotide microarray analysis Total RNA from cortical tissues from each rat was isolated with ISOGEN (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions. The Affymetrix Rat 230A oligonucleotide array sets (Affymetrix, Santa Clara, CA, USA), which contain 15,924 probe sets, were used to compare gene expression profiles of baseline, 3-and 7-day-group rats according to the manufacturer's instructions. Briefly, biotinylated cRNAs were synthesized and hybridized to the GeneChip probe arrays, which were then washed in washing solution, stained with streptavidin-phycoerythrin, and scanned. The data obtained were analyzed with Affymetrix Microarray Suite v5.0. All time points were microarrayed as experimental duplicate.
Cell culture IRPTCs (a generous gift from Dr Julie R. Ingelfinger, MGH, Boston, MA, USA) and HRE-LUC stably transfected IRPTCs were cultured under the previously described conditions. 56 Stable transfectants of HEK293T expressing HRE-driven luciferase were selected by geneticin and were cultured in Dulbecco's modified Eagle's medium (Nissui, Tokyo, Japan) supplemented with 10% fetal bovine serum (JRH Biosciences, Lenexa, KS, USA), 50 U/ml penicillin, 50 mg/ml streptomycin. The cells were grown at 37 1C under a humidified atmosphere of 5% CO 2 /95% air. Hypoxia was provided by exposure to 1% O 2 /5% CO 2 with the balance as nitrogen in a multigas incubator, APM-30D (ASTEC, Fukuoka, Japan). Stimulation by hypoxia, zinc chloride at 33.3 mM, hydrogen peroxide at 100 mM (Wako, Tokyo, Japan) or TNF-a at 10 ng/ml (R&D Systems, Minneapolis, MN, USA) was initiated at 70% confluence. Cells were treated by the addition of MT-I (Sigma-Aldrich, St. Louis, MO, USA), with and without iron(II) sulfite (Wako), rapamycin at 50 nM (Sigma-Aldrich), or U0126 at 3 mM (Cell Signaling, Danvers, MA, USA) in a serum free condition for 24 h, followed by measurement of LUC activity of the cell lysate.
Real-time quantitative RT-PCR
Total RNA from cortical tissues from each rat or IRPTC was isolated utilizing ISOGEN, and was reverse-transcribed with Im-Prom II reverse transcription kit (Promega, Madison, WI, USA). cDNA (1 mg) was subjected to real-time RT-PCR (iCycler iQ; Bio-Rad, Hercules, CA, USA) utilizing SYBR Green Supermix. The relative amounts of genes were calculated with calibration using expression levels of b-actin. Corresponding primers have been described in the literature 57, 58 
Immunohistochemistry
For MT staining, methyl Carnoy's-fixed, paraffin-embedded sections (3 mm) were probed with anti-MT (1/100; Zymed, Carlsbad, CA, USA), biotinylated anti-mouse IgG (1/400; Vector Laboratories, Burlingame, CA, USA) and HRP-avidin. The slides were then developed with diaminobenzidine (Wako), followed by counter staining with methyl green. Specificity of the antibody was further examined by an absorption test of the antibody with MT in immunohistochemical analysis.
Western blotting analyses
Whole proteins for analysis of MT and actin were prepared using NP-40 lysis buffer (150 mmol/l NaCl, 1% NP-40, and 50 mmol/l Tris-HCl, pH 8.0). Nuclear extracts for analysis of HIF-1a were prepared from cultured cells using a nuclear extraction kit (Pierce, 
Transfection of MT-overexpressing vectors
An open reading frame coding for the human MTs (hMTs) was obtained by RT-PCR using total RNA of human renal proximal tubule epithelial cells (Lonza, Walkersville, MD, USA) as a template. Primers used were forward: GAA ATG GAC CCC AAC TGC TCC TGC-3 0 , reverse: 5 0 -TCA GGC ACA GCA GCT GCA CTT CTC-3 0 for MT-1 and forward: 5 0 -GCC ATG GAT CCC AAC TGC TCC TGC-3 0 , reverse: 5 0 -GGA GCG GGG CTG TCC CAG CAT CAG-3 0 for MT-2, respectively. The PCR fragments of 186 nt for human MT-1E (hMT-1) and 206 nt for human MT-2A (hMT-2) were subcloned into pGMT-T Easy (Promega) and was processed to dideoxy-DNA sequencing. The sequence-confirmed fragment was digested with ApaI and PstI and again incorporated to the mammalian expression vector, pcDNA4/TO/myc-HisA (Invitrogen, Carlsbad, CA, USA). Then, the vector plasmids (pcDNA-hMT-1 and hMT-2) were transiently transfected to HEK293T, which stably expressed HREdriven luciferase, using Lipofectamine reagent (Invitrogen) according to the manufacturer's protocol. At 36 h after transfection, cell lysate was collected for evaluation of LUC activity.
Statistical analysis
Values were presented as mean±s.e.m. One-way analysis of variance followed by the least significant difference method was used to determine differences more than two groups for all continuous parameters, whereas Student's t-test was used for two-group data. The significance level was set at Po0.05 for all tests (SPSS for Windows 11.0) (SPSS Inc., Chicago, IL, USA).
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